CRNX CIK: 1658247

Crinetics Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotechnology
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
4.01
FY24:
1.04
FY25:
6.62
(positive)
Change from FY21 to FY25
millions USD
FY21:
−108
FY22:
−168
FY23:
−223
FY24:
−339
FY25:
−517
(positive)
Change from FY21 to FY25
millions USD
FY21:
−107
FY22:
−167
FY23:
−222
FY24:
−336
FY25:
−513
(positive)
Change from FY21 to FY25
millions USD
FY21:
−108
FY22:
−164
FY23:
−215
FY24:
−298
FY25:
−465
(positive)
Change from FY21 to FY25
millions USD
FY21:
−108
FY22:
−164
FY23:
−215
FY24:
−298
FY25:
−465

All amounts in millions USD Data sources:SEC EDGARTwelve Data